1. Home
  2. PCSA vs TANH Comparison

PCSA vs TANH Comparison

Compare PCSA & TANH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Processa Pharmaceuticals Inc.

PCSA

Processa Pharmaceuticals Inc.

N/A

Current Price

$2.41

Market Cap

6.3M

Sector

Health Care

ML Signal

N/A

Logo Tantech Holdings Ltd.

TANH

Tantech Holdings Ltd.

N/A

Current Price

$0.70

Market Cap

6.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PCSA
TANH
Founded
2011
2001
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
6.2M
IPO Year
2012
2013

Fundamental Metrics

Financial Performance
Metric
PCSA
TANH
Price
$2.41
$0.70
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
39.3K
45.9K
Earning Date
05-07-2026
12-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.17
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.73
52 Week High
$8.88
$2.59

Technical Indicators

Market Signals
Indicator
PCSA
TANH
Relative Strength Index (RSI) 43.95 25.58
Support Level $0.21 N/A
Resistance Level $2.56 $1.05
Average True Range (ATR) 0.33 0.12
MACD -0.05 -0.02
Stochastic Oscillator 25.41 4.25

Price Performance

Historical Comparison
PCSA
TANH

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

About TANH Tantech Holdings Ltd.

Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company, through its subsidiaries, is engaged in the production and distribution of household products along with a trading business, which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments: the Consumer Product segment, and the Electric Vehicle (EV) segment.

Share on Social Networks: